エーザイの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/06/23 | 5,377 | 5,488 | 5,366 | 5,484 | +132 | +2.5% | 855,900 |
2022/06/22 | 5,296 | 5,371 | 5,272 | 5,352 | +68 | +1.3% | 773,500 |
2022/06/21 | 5,228 | 5,295 | 5,198 | 5,284 | +94 | +1.8% | 776,000 |
2022/06/20 | 5,196 | 5,198 | 5,136 | 5,190 | +81 | +1.6% | 716,200 |
2022/06/17 | 5,031 | 5,110 | 5,011 | 5,109 | -34 | -0.7% | 1,503,800 |
2022/06/16 | 5,161 | 5,194 | 5,131 | 5,143 | +59 | +1.2% | 678,800 |
2022/06/15 | 5,202 | 5,206 | 5,077 | 5,084 | -105 | -2% | 934,200 |
2022/06/14 | 5,188 | 5,195 | 5,135 | 5,189 | -60 | -1.1% | 1,045,200 |
2022/06/13 | 5,306 | 5,334 | 5,232 | 5,249 | -146 | -2.7% | 807,600 |
2022/06/10 | 5,386 | 5,407 | 5,288 | 5,395 | -91 | -1.7% | 1,604,600 |
2022/06/09 | 5,415 | 5,505 | 5,415 | 5,486 | +56 | +1% | 864,400 |
2022/06/08 | 5,306 | 5,447 | 5,301 | 5,430 | +147 | +2.8% | 1,172,500 |
2022/06/07 | 5,257 | 5,308 | 5,240 | 5,283 | +26 | +0.5% | 704,400 |
2022/06/06 | 5,190 | 5,279 | 5,177 | 5,257 | +51 | +1% | 838,700 |
2022/06/03 | 5,187 | 5,215 | 5,148 | 5,206 | +46 | +0.9% | 898,400 |
2022/06/02 | 5,271 | 5,271 | 5,150 | 5,160 | -121 | -2.3% | 1,306,300 |
2022/06/01 | 5,308 | 5,364 | 5,262 | 5,281 | -17 | -0.3% | 1,073,600 |
2022/05/31 | 5,410 | 5,455 | 5,298 | 5,298 | -99 | -1.8% | 2,948,300 |
2022/05/30 | 5,366 | 5,433 | 5,348 | 5,397 | +78 | +1.5% | 1,066,100 |
2022/05/27 | 5,327 | 5,345 | 5,275 | 5,319 | +47 | +0.9% | 831,100 |
2022/05/26 | 5,324 | 5,369 | 5,266 | 5,272 | -52 | -1% | 1,116,700 |
2022/05/25 | 5,425 | 5,452 | 5,323 | 5,324 | -118 | -2.2% | 1,085,400 |
2022/05/24 | 5,561 | 5,561 | 5,442 | 5,442 | -142 | -2.5% | 865,300 |
2022/05/23 | 5,520 | 5,585 | 5,517 | 5,584 | +127 | +2.3% | 882,600 |
2022/05/20 | 5,503 | 5,520 | 5,427 | 5,457 | -13 | -0.2% | 654,600 |
2022/05/19 | 5,481 | 5,495 | 5,417 | 5,470 | -111 | -2% | 945,400 |
2022/05/18 | 5,547 | 5,680 | 5,546 | 5,581 | +34 | +0.6% | 731,000 |
2022/05/17 | 5,612 | 5,632 | 5,533 | 5,547 | -35 | -0.6% | 831,200 |
2022/05/16 | 5,646 | 5,736 | 5,575 | 5,582 | -21 | -0.4% | 925,800 |
2022/05/13 | 5,555 | 5,670 | 5,498 | 5,603 | +214 | +4% | 1,548,200 |
2022/05/12 | 5,474 | 5,485 | 5,380 | 5,389 | -167 | -3% | 1,194,900 |
2022/05/11 | 5,555 | 5,604 | 5,530 | 5,556 | -36 | -0.6% | 644,200 |
2022/05/10 | 5,518 | 5,608 | 5,500 | 5,592 | +57 | +1% | 646,200 |
2022/05/09 | 5,622 | 5,640 | 5,500 | 5,535 | -122 | -2.2% | 956,400 |
2022/05/06 | 5,640 | 5,684 | 5,504 | 5,657 | -78 | -1.4% | 1,422,700 |
2022/05/02 | 5,650 | 5,745 | 5,605 | 5,735 | +71 | +1.3% | 859,000 |
2022/04/28 | 5,508 | 5,675 | 5,500 | 5,664 | +177 | +3.2% | 1,029,000 |
2022/04/27 | 5,520 | 5,536 | 5,481 | 5,487 | -117 | -2.1% | 971,900 |
2022/04/26 | 5,595 | 5,625 | 5,558 | 5,604 | +8 | +0.1% | 591,200 |
2022/04/25 | 5,584 | 5,650 | 5,563 | 5,596 | -57 | -1% | 628,300 |
2022/04/22 | 5,688 | 5,688 | 5,601 | 5,653 | -123 | -2.1% | 807,000 |
2022/04/21 | 5,757 | 5,792 | 5,733 | 5,776 | +45 | +0.8% | 821,400 |
2022/04/20 | 5,711 | 5,756 | 5,656 | 5,731 | +40 | +0.7% | 803,700 |
2022/04/19 | 5,718 | 5,738 | 5,661 | 5,691 | +2 | ±0% | 603,100 |
2022/04/18 | 5,708 | 5,717 | 5,628 | 5,689 | -47 | -0.8% | 671,800 |
2022/04/15 | 5,739 | 5,758 | 5,680 | 5,736 | -41 | -0.7% | 525,500 |
2022/04/14 | 5,769 | 5,811 | 5,744 | 5,777 | +32 | +0.6% | 529,800 |
2022/04/13 | 5,602 | 5,746 | 5,592 | 5,745 | +149 | +2.7% | 1,027,200 |
2022/04/12 | 5,767 | 5,782 | 5,555 | 5,596 | -322 | -5.4% | 1,648,500 |
2022/04/11 | 5,994 | 6,039 | 5,874 | 5,918 | -53 | -0.9% | 751,200 |
701~
750
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
エーザイ | 427,100円 | +1.7% | -2.9% | 3.75% | 28.02倍 | 1.47倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 245,700円 | +5.7% | +3.9% | 2.50% | 12.22倍 | 1.62倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
協和キリン | 219,100円 | -3.5% | -11.3% | 2.74% | 20.12倍 | 1.35倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
小野薬 | 166,700円 | -3.1% | -63.4% | 4.80% | 15.66倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム